Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: Five-year results with epirubicin and ifosfamide

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3555-3559

  Ottaiano, A ^a   De Chiara, A ^a   Fazioli, F ^a   De Rosa, V ^a   Ravo, V ^a   Boccia, V ^a   Botti, G ^a   Petrillo, A ^a   Fiore, F ^a   Mori, S ^a   Mozzillo, N ^a   Iaffaioli, V R ^a   Apice, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Epirubicin; Ifosfamide; Neoadjuvant chemotherapy; Soft tissue sarcoma

Indexed keywords

EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; DISEASE CONTROL; FEMALE; HUMAN; LIMB SALVAGE; LIVER TOXICITY; MALE; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; THROMBOCYTHEMIA; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0036875142     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dirix LY and van Oosterom AT: Soft tissue sarcoma in adults. Curr Opin Oncol 11(4): 285-95, 1999.
2. Weiss SW and Goldblum JR: General Considerations, in Enzinger and Weiss's Soft Tissue Tumors. St Louis, MO, Mosby, 2001, pp 1-18.
3. Wynendaele W and van Oosterom AT: Neoadjuvant/primary chemotherapy in cancer treatment: what advantage? Forum(Genova) 93(3): 212-21, 1999.
4. Meric F, Milas M, Hunt KK, Hess KR, Pisters PW, Hildebrandt G, Patel SR, Benjamin RS, Plager C, Papadopolous NE, Burgess MA, Pollock RE and Feig BW: Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol 18(19): 3378-83, 2000.
5. Bacci G, Ferrari S, Bertoni F, Donati D, Bacchini P, Longhi A, Brach Del Prever A, Forni C and Rimondini S: Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the Istituto Rizzoli. J Clin Oncol 18(4): 885-92, 2000.
6. Picci P, Bacci G, Ferrari S and Mercuri M: Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone in osteosarcoma located in the extremities: analogies and differences between the two tumors. Ann Oncol 8(11): 1107-15, 1997.
7. Temple WJ, Temple CL, Arthur K, Schachar NS, Paterson AH and Crabtree TS: Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas. Ann Surg Oncol 4(7): 586-90, 1997.
8. Rahoty P and Konya A: Results of preoperative neoadjuvant chemotherapy and surgery in the management of patients with soft tissue sarcoma. Eur J Surg Oncol 19(6): 641-5, 1993.
9. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: metanalysis of individual data. Lancet 350 (9092): 1647-54, 1997.
10. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, Apice G, Zmerly H, Serraino D and Picci P: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19(5): 1238-47, 2001.
11. Toma S, Palumbo R, Canavese G, Albanese E, Cantoni E, Barisone A, Reggiardo G, Rosso R and Santi L: Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas. Cancer Chemother Pharmacol 31 Suppl 2: S22-27, 1994.
12. Chevallier B, Leyvraz S, Olivier JP, Fargeot P, Facchini T and Vo Van ML: Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study. Cancer Invest 11(2): 135-9, 1993.
13. Frustaci S, Foladore S, Buonadonna A, De Paoli A, Crivellari D, Carbone A, Sorio R, Morassut S and Monfardini S: Epirubicin and ifosfamide in advanced soft tissue sarcomas. Ann Oncol 4(8): 669-72, 1993.
14. Reichardt P, Tilgner J, Hohenberger P and Dorken B: Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgastrim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study. J Clin Oncol 16(4): 1438-43, 1998.
15. Palumbo R, Neumaier C, Cosso M, Bertero G, Raffo P, Spadini N, Valente S, Villani G, Pastorino M and Toma S: Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study. Eur J Cancer 35(1): 66-72, 1999.
16. Frustaci S, Buonadonna A, Romanini A, Comandone A, Dalla Palma M, Gamucci T, Verusio C, Lionetto R, Dani C, Casali P and Santoro A: Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors. Tumori 85(4): 229-33, 1999.
17. Serrone L, Zeuli M, Gamucci T, Nardi M and Cognetti F: A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule. Cancer Chemother Pharmacol 47(3): 206-10, 2001.